Sara is a research fellow at the Centre for Health Economics, Monash Business School. She works with the health technology assessment team to evaluate the comparative clinical and cost-effectiveness of medical technologies for funding within national insurance schemes. This work informs recommendations by the Pharmaceutical Benefits Advisory Committee (PBAC) in Australia and the Agency for Care and Effectiveness (ACE) in Singapore.
Sara has a background in systematic reviews, outcomes research, clinical and cost-effectiveness evaluations. She holds a MSc in Public Health from the London School of Hygiene and Tropical Medicine (LSHTM). Sara's previous work includes the development and evaluation of health technology assessments (HTA) for the Medical Services Advisory Committee (MSAC) at the University of Sydney and clinical guidelines for the National Institute for Health and Care Excellence (NICE) in the UK.
Other research interests include economic modelling, health-related quality of life measures, and cost-effectiveness analysis alongside clinical trials.